42
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Relationships between gut microbiota, plasma metabolites, and metabolic syndrome traits in the METSIM cohort

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The gut microbiome is a complex and metabolically active community that directly influences host phenotypes. In this study, we profile gut microbiota using 16S rRNA gene sequencing in 531 well-phenotyped Finnish men from the Metabolic Syndrome In Men (METSIM) study.

          Results

          We investigate gut microbiota relationships with a variety of factors that have an impact on the development of metabolic and cardiovascular traits. We identify novel associations between gut microbiota and fasting serum levels of a number of metabolites, including fatty acids, amino acids, lipids, and glucose. In particular, we detect associations with fasting plasma trimethylamine N-oxide (TMAO) levels, a gut microbiota-dependent metabolite associated with coronary artery disease and stroke. We further investigate the gut microbiota composition and microbiota–metabolite relationships in subjects with different body mass index and individuals with normal or altered oral glucose tolerance. Finally, we perform microbiota co-occurrence network analysis, which shows that certain metabolites strongly correlate with microbial community structure and that some of these correlations are specific for the pre-diabetic state.

          Conclusions

          Our study identifies novel relationships between the composition of the gut microbiota and circulating metabolites and provides a resource for future studies to understand host–gut microbiota relationships.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13059-017-1194-2) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health

          The colon is inhabited by a dense population of microorganisms, the so-called “gut microbiota,” able to ferment carbohydrates and proteins that escape absorption in the small intestine during digestion. This microbiota produces a wide range of metabolites, including short chain fatty acids (SCFA). These compounds are absorbed in the large bowel and are defined as 1-6 carbon volatile fatty acids which can present straight or branched-chain conformation. Their production is influenced by the pattern of food intake and diet-mediated changes in the gut microbiota. SCFA have distinct physiological effects: they contribute to shaping the gut environment, influence the physiology of the colon, they can be used as energy sources by host cells and the intestinal microbiota and they also participate in different host-signaling mechanisms. We summarize the current knowledge about the production of SCFA, including bacterial cross-feedings interactions, and the biological properties of these metabolites with impact on the human health.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity

            The gut microbiota is involved in metabolic and immune disorders associated with obesity and type 2 diabetes. We previously demonstrated that prebiotic treatment may significantly improve host health by modulating bacterial species related to the improvement of gut endocrine, barrier and immune functions. An analysis of the gut metagenome is needed to determine which bacterial functions and taxa are responsible for beneficial microbiota–host interactions upon nutritional intervention. We subjected mice to prebiotic (Pre) treatment under physiological (control diet: CT) and pathological conditions (high-fat diet: HFD) for 8 weeks and investigated the production of intestinal antimicrobial peptides and the gut microbiome. HFD feeding significantly decreased the expression of regenerating islet-derived 3-gamma (Reg3g) and phospholipase A2 group-II (PLA2g2) in the jejunum. Prebiotic treatment increased Reg3g expression (by ∼50-fold) and improved intestinal homeostasis as suggested by the increase in the expression of intectin, a key protein involved in intestinal epithelial cell turnover. Deep metagenomic sequencing analysis revealed that HFD and prebiotic treatment significantly affected the gut microbiome at different taxonomic levels. Functional analyses based on the occurrence of clusters of orthologous groups (COGs) of proteins also revealed distinct profiles for the HFD, Pre, HFD-Pre and CT groups. Finally, the gut microbiota modulations induced by prebiotics counteracted HFD-induced inflammation and related metabolic disorders. Thus, we identified novel putative taxa and metabolic functions that may contribute to the development of or protection against the metabolic alterations observed during HFD feeding and HFD-Pre feeding.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome.

              Obesity, diabetes, and metabolic syndrome result from complex interactions between genetic and environmental factors, including the gut microbiota. To dissect these interactions, we utilized three commonly used inbred strains of mice-obesity/diabetes-prone C57Bl/6J mice, obesity/diabetes-resistant 129S1/SvImJ from Jackson Laboratory, and obesity-prone but diabetes-resistant 129S6/SvEvTac from Taconic-plus three derivative lines generated by breeding these strains in a new, common environment. Analysis of metabolic parameters and gut microbiota in all strains and their environmentally normalized derivatives revealed strong interactions between microbiota, diet, breeding site, and metabolic phenotype. Strain-dependent and strain-independent correlations were found between specific microbiota and phenotypes, some of which could be transferred to germ-free recipient animals by fecal transplantation. Environmental reprogramming of microbiota resulted in 129S6/SvEvTac becoming obesity resistant. Thus, development of obesity/metabolic syndrome is the result of interactions between gut microbiota, host genetics, and diet. In permissive genetic backgrounds, environmental reprograming of microbiota can ameliorate development of metabolic syndrome.
                Bookmark

                Author and article information

                Contributors
                (372) 737 4039 , elin.org@ut.ee
                yuna.blum@gmail.com
                Silva.Kasela@ut.ee
                mehrabi.m@gmail.com
                johanna.kuusisto@kuh.fi
                antti.kangas@computationalmedicine.fi
                pasi.soininen@uef.fi
                WANGZ2@ccf.org
                mika.ala-korpela@computationalmedicine.fi
                HAZENS@ccf.org
                markku.laakso@uef.fi
                (310) 825-1359 , jlusis@mednet.ucla.edu
                Journal
                Genome Biol
                Genome Biol
                Genome Biology
                BioMed Central (London )
                1474-7596
                1474-760X
                13 April 2017
                13 April 2017
                2017
                : 18
                : 70
                Affiliations
                [1 ]GRID grid.19006.3e, Department of Medicine, , University of California, Los Angeles, ; Los Angeles, CA 90095 USA
                [2 ]GRID grid.10939.32, Estonian Genome Centre, , University of Tartu, ; Tartu, 51010 Estonia
                [3 ]GRID grid.10939.32, , Institute of Molecular and Cell Biology, University of Tartu, ; Tartu, 51010 Estonia
                [4 ]GRID grid.9668.1, , Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, ; Kuopio, Finland
                [5 ]GRID grid.410705.7, , Kuopio University Hospital, ; Kuopio, Finland
                [6 ]GRID grid.10858.34, Computational Medicine, Faculty of Medicine, , University of Oulu and Biocenter Oulu, ; Oulu, Finland
                [7 ]GRID grid.9668.1, NMR metabolomics Laboratory, , School of Pharmacy, University of Eastern Finland, ; Kuopio, Finland
                [8 ]GRID grid.239578.2, Department of Cellular and Molecular Medicine, , Cleveland Clinic, ; Cleveland, OH 44195 USA
                [9 ]GRID grid.5337.2, Computational Medicine, School of Social and Community Medicine, , University of Bristol and Medical Research Council Integrative Epidemiology Unit at the University of Bristol, ; Bristol, UK
                [10 ]GRID grid.19006.3e, Department of Human Genetics, , University of California, Los Angeles, ; Los Angeles, CA 90095 USA
                [11 ]GRID grid.19006.3e, Department of Microbiology, Immunology and Molecular Genetics, , University of California, Los Angeles, ; Los Angeles, CA 90095 USA
                Article
                1194
                10.1186/s13059-017-1194-2
                5390365
                28407784
                15ed227b-dfa1-4b14-a541-997a848a846a
                © The Author(s). 2017

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 27 November 2016
                : 16 March 2017
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000002, National Institutes of Health;
                Award ID: HL028481
                Award ID: HL30568
                Award ID: DK094311
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100004963, Seventh Framework Programme;
                Award ID: FP7-MC-IOF grant no 330381
                Award Recipient :
                Categories
                Research
                Custom metadata
                © The Author(s) 2017

                Genetics
                host-microbiota interactions,tmao,metabolic traits,serum metabolites,type 2 diabetes
                Genetics
                host-microbiota interactions, tmao, metabolic traits, serum metabolites, type 2 diabetes

                Comments

                Comment on this article